(CHRS) |
| 0 (0%) 07-29 02:28 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 1.71 |
| Resistance 1: | 1.58 |
| Pivot price: | 1.47 |
| Support 1: | 1.36 |
| Support 2: | 1.13 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | -1.420 |
| Book Value | 0.510 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.207 |
| Profit Margin (%) | 397.30 |
| Operating Margin (%) | -293.67 |
| Return on Assets (ttm) | -32.8 |
| Return on Equity (ttm) | 0.0 |
Company news
Mon, 27 Jul 2026
BlackRock (CHRS holder) discloses 8.93M Coherus Oncology shares under sole control - Stock Titan
Mon, 27 Jul 2026
Coherus BioSciences Inc (CHRS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Mon, 27 Jul 2026
Coherus BioSciences Inc (CHRS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Thu, 23 Jul 2026
COHERUS ONCOLOGY INC (CHRS) Stock Chart - ChartMill
Wed, 22 Jul 2026
Coherus to webcast second-quarter results Aug. 5 at 5 p.m. - Stock Titan
Wed, 08 Jul 2026
Coherus Oncology (CHRS) The Citizens JMP Life Sciences Conference 2025 Summary - Quartr
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
